Crystal structure of steroid reductase SRD5A reveals conserved steroid reduction mechanism

Autor: Ying-Chih Chiang, Ruobing Ren, Yufei Han, Zhen Li, Pengliang Chi, Fuping Li, Bo Sun, Qisheng Wang, Zhenfei Li, Youli Zhou, Dong Deng, Fuxing Wang, Sheng Wang, Qingjie Xiao, Wenping Lv, Lizhe Zhu, Bin Pang, Qian Zhuang
Rok vydání: 2020
Předmět:
0301 basic medicine
Science
medicine.medical_treatment
Mutant
Coenzymes
General Physics and Astronomy
Reductase
Crystallography
X-Ray

General Biochemistry
Genetics and Molecular Biology

Article
Cofactor
Steroid
03 medical and health sciences
Structure-Activity Relationship
0302 clinical medicine
5-alpha Reductase Inhibitors
3-Oxo-5-alpha-Steroid 4-Dehydrogenase
Bacterial Proteins
Proteobacteria
medicine
Structure–activity relationship
Binding site
Testosterone
Steroid hormones
X-ray crystallography
Multidisciplinary
Binding Sites
biology
Chemistry
Hydrogen Bonding
General Chemistry
Hyperplasia
medicine.disease
Transmembrane protein
030104 developmental biology
SRD5A1
Biochemistry
030220 oncology & carcinogenesis
Drug Design
Enzyme mechanisms
Protein structure predictions
biology.protein
Steroids
Oxidation-Reduction
NADP
Hormone
Zdroj: Nature Communications
Nature Communications, Vol 12, Iss 1, Pp 1-10 (2021)
Popis: Steroid hormones are essential in stress response, immune system regulation, and reproduction in mammals. Steroids with 3-oxo-Δ4 structure, such as testosterone or progesterone, are catalyzed by steroid 5α-reductases (SRD5As) to generate their corresponding 3-oxo-5α steroids, which are essential for multiple physiological and pathological processes. SRD5A2 is already a target of clinically relevant drugs. However, the detailed mechanism of SRD5A-mediated reduction remains elusive. Here we report the crystal structure of PbSRD5A from Proteobacteria bacterium, a homolog of both SRD5A1 and SRD5A2, in complex with the cofactor NADPH at 2.0 Å resolution. PbSRD5A exists as a monomer comprised of seven transmembrane segments (TMs). The TM1-4 enclose a hydrophobic substrate binding cavity, whereas TM5-7 coordinate cofactor NADPH through extensive hydrogen bonds network. Homology-based structural models of HsSRD5A1 and -2, together with biochemical characterization, define the substrate binding pocket of SRD5As, explain the properties of disease-related mutants and provide an important framework for further understanding of the mechanism of NADPH mediated steroids 3-oxo-Δ4 reduction. Based on these analyses, the design of therapeutic molecules targeting SRD5As with improved specificity and therapeutic efficacy would be possible.
Steroid 5α-reductase 2 (SRD5A2), a testosterone metabolism enzyme, is implicated in human disease. Structural and biochemical analyses of PbSRD5A, a bacterial homolog, reveal SRD5A2 substrate binding pocket and provide framework for the design of new drugs targeting this enzyme.
Databáze: OpenAIRE